In vitro diagnostic reagent for cardiac biomarker detection. Enables rapid assessment of cardiac function and myocardial injury.
Manufactured by
Nanjing, China
Lansion Biotechnology Co., Ltd.(Lansionbio) was established in Nanjing, China in 2016. As one high-tech enterprise and key technology-based enterprise, Lansionbio is committed to the research development, production, sales and service of in vitro diagnostic reagents and devices. Through the integrated multi-platform POCT workstation, it provides medical units and families with comprehensive solutions for on-site rapid detection, and has become a representative enterprise of the new generation of laboratory medicine industry ecology in China. Since 2020, Lansionbio has been actively involved in the prevention and control of the global COVID-19 epidemic, and its related products have obtained CE certification and product registration in many countries, and are exported to more than 50 countries and regions outside of China.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
ChangChun WanCheng Bio-Electron Co., Ltd.
China · 1 relevant product
Shenzhen Xilaiheng Medical Electronics Co., Ltd
China · 1 relevant product
GenSure Biotech Inc.
China · 2 relevant products
Acon Biotech (Hangzhou) Co., Ltd.
China · 1 relevant product
AEHEALTH Limited
China · 2 relevant products
InTec PRODUCTS, INC.
China · 1 relevant product
Nanjing Synthgene Medical Technology Co., Ltd.
China · 2 relevant products
Hangzhou Frenovo Biotech Co., Ltd
China · 2 relevant products
HANGZHOU LAIHE BIOTECH CO.,LTD
China · 3 relevant products
Jiangsu Sunlant Bioengineering Co., Ltd.
China · 3 relevant products
70 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →6 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 113 closest product alternatives
ChangChun WanCheng Bio-Electron Co., Ltd. · China
Rapid immunoassay test for detection of cardiac biomarkers indicating myocardial injury. Supports acute coronary syndrome diagnosis and cardiac event assessment.
Shenzhen Xilaiheng Medical Electronics Co., Ltd · China
IVD kit for detection and quantification of troponin and other cardiac markers. Used for diagnosis and monitoring of myocardial infarction in acute care settings.
GenSure Biotech Inc. · China
In vitro diagnostic test for detection of cardiac-related biomarkers indicating myocardial injury or cardiac function status. Supports cardiovascular risk assessment and acute coronary syndrome evaluation.
Acon Biotech (Hangzhou) Co., Ltd. · China
Rapid diagnostic test for cardiac markers including myocardial infarction indicators. Enables quick assessment of cardiac events in clinical laboratories.
AEHEALTH Limited · China
Diagnostic test for high-sensitivity cardiac troponin I (Hs-cTnI) and other cardiac markers. Provides rapid assessment for acute coronary syndrome evaluation.
InTec PRODUCTS, INC. · China
Rapid immunochromatographic assay for qualitative detection of cardiac biomarkers. Point-of-care diagnostic test for cardiovascular event assessment.
Nanjing Synthgene Medical Technology Co., Ltd. · China
A diagnostic test for cardiac risk markers assessment in cardiovascular health evaluation. Detects biomarkers indicative of potential cardiac conditions.
Hangzhou Frenovo Biotech Co., Ltd · China
A rapid diagnostic test for detecting cardiac markers to assess heart disease and cardiac events. This test provides quick results for emergency cardiac screening.
HANGZHOU LAIHE BIOTECH CO.,LTD · China
Quantitative fluorescence immunoassay test panels for cTnI, NT-proBNP, CK-MB, and D-Dimer that provide highly accurate concentration readouts within 15 minutes. Designed to empower chest pain centers with rapid, accurate results crucial for acute myocardial infarction intervention.
Jiangsu Sunlant Bioengineering Co., Ltd. · China
In vitro diagnostic test kit designed for detection of cardiac-related biomarkers using microarray chemiluminescence technology. The platform enables parallel measurement of multiple heart-specific markers with high sensitivity and specificity.
Beijing Hotgen Biotech Co.,Ltd · China
Rapid immunoassay test kit for cardiac biomarker detection, enabling point-of-care diagnosis of acute myocardial infarction and heart failure. Single-use disposable format delivers results within 10-15 minutes, supporting emergency department triage and risk stratification in acute cardiac care settings.
ProGnosis Biotech S.A. · Greece
ELISA-based diagnostic kit for cardiac marker detection in clinical cardiology applications. Advanced testing solution under development utilizing validated antigen-antibody technology.
101 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products